Global Product Lead (GPL) – Anifrolumab
AstraZenecaUs - durham - ncUpdate time: January 21,2021
Job Description

Opportunity:     Global Product Lead (GPL) – Anifrolumab

Locations:         Gaithersburg & Durham (US), Cambridge (UK), Gothenburg, Sweden

Salary:  Competitive with Excellent Company Benefits

At AstraZeneca, we are not afraid to do things differently. We are resetting expectations of what a bio-pharmaceutical company can be. This means we are opening up new ways to work, pioneering cutting edge methods and bringing unexpected teams together.

We pride ourselves on making sure that each decision we make puts patient needs first. This mindset means that our people have permission to take the more unusual path. If they can think of a better, smarter way in which we can change lives through science, we want to hear it.

As a Global Product Lead for anifrolumab you will have the responsibility for therapeutically aligned Indication strategy which is one of the key pillars of the Asset strategy. Together with the cross-functional Indication Team you will design the Indication strategy in line with the Asset strategy and through the brand’s life cycle management (LCM).  You will also ensure that functional expertise is brought to bear on the Global Product Team (GPT) discussions.  You will lead the cross-functional execution of the approved Indication strategy once approved by the GPT and governance.

The Global Product Lead will report to the Global Franchise Head of anifrolumab and be responsible for:

  • Accountable for creation and operational implementation of the Indication strategy aligned with the Asset strategy through the product/indication lifecycle, above and beyond LCM.
  • Ensure Indication strategy is innovative, with a balanced focus on safety and efficacy for regulatory approval plus value for market access.
  • Working collaboratively with Global team to generate, evaluate and deliver robust commercial options and strategies for the LCM programs and relevant business and commercial development opportunity assessments. This includes defining the range of LCM investment options/business cases and making recommendations for investment decisions Defining and creating the content of Indication business cases that deliver regulatory approval worldwide (health authority needs) as well as reimbursement (Payer needs).
  • Delivering of governance-approved business cases within tolerance on time, cost and quality, working with functional management as required to resolve issues.
  • Delivering the Indication Target Product Profile (TPP) and Target Product Claims (TPC).
  • Ensuring role modelling for internal stakeholders and KEE engagement in strategy development and science cascade.
  • Ensuring effective and transparent risk, opportunity and issue management at strategic, tactical and operational levels.
  • Simplifying the complex, anticipating obstacles and barriers and working around them by integrating robust scientific, competitive intelligence, KOL and payer insights. Seeking partners and collaborators that share our passion for science.
  • Ensuring appropriate Governance and Compliance and protects AZ’s Rights, Data and Intellectual Property.
  • Managing performance with cross-functional team. Building and effectively leading high performing cross-functional teams.

You must meet the essential qualifications and experience listed below:

  • MD or PhD in a scientific or technical discipline
  • Full grasp of the latest research and thinking in biologic candidate drugs particularly in complex diseases, especially those that are immune-mediated
  • Ability to build strong KEE networks and ability to shape the market for rheumatologic biologic candidate drugs
  • Ability to become expert in the latest research and thinking in candidate targeted biologic drugs
  • Solid knowledge of the competitive landscape and activities
  • Conceptual, analytical and strategic thinking
  • Ability to influence strategically across all levels of the organisation
  • Proven matrix leadership to accomplish team and organizational objectives
  • Experience of leading a development team and working in a Global environment
  • Significant understanding of the overall drug development process
  • Demonstrated ability to shape and deliver business cases
  • Excellent written and verbal communication skills as well as proven negotiation, collaboration and interpersonal leadership skills
  • Mastery of Project Management with an ability to lead cross functional working groups and teams
  • Hands-on experience of managing project budgets
  • Willingness to travel both domestically and internationally

If you are interested in this position, please apply by submitting your CV by 3rd February 2021
 

AstraZeneca is an equal opportunity employer. AstraZeneca will consider all qualified applicants for employment without discrimination on grounds of disability, gender or gender orientation, pregnancy or maternity leave status, race or national or ethnic origin, age, religion or belief, gender identity or re-assignment, marital or civil partnership status, protected veteran status (if applicable) or any other characteristic protected by law.

Date Posted

20-Jan-2021

Closing Date

02-Feb-2021

AstraZeneca embraces diversity and equality of opportunity.  We are committed to building an inclusive and diverse team representing all backgrounds, with as wide a range of perspectives as possible, and harnessing industry-leading skills.  We believe that the more inclusive we are, the better our work will be.  We welcome and consider applications to join our team from all qualified candidates, regardless of their characteristics.  We comply with all applicable laws and regulations on non-discrimination in employment (and recruitment), as well as work authorization and employment eligibility verification requirements.

Get email alerts for the latest"Global Product Lead (GPL) – Anifrolumab jobs in Us - durham - nc"